Editas Medicine
EDIT
EDIT
191 hedge funds and large institutions have $90.9M invested in Editas Medicine in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
191
Holders Change
-3
Holders Change %
-1.55%
% of All Funds
2.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
48
Reduced
52
Closed
27
Calls
$1.83M
Puts
$596K
Net Calls
+$1.24M
Net Calls Change
+$907K
Top Buyers
| 1 |
Millennium Management
New York
|
+$3.5M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$1.86M |
| 3 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
+$1.39M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.15M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$789K |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$3.02M |
| 2 |
Morgan Stanley
New York
|
-$2.72M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.29M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$964K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$790K |
